Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting.
about
C4.4A as a candidate marker in the diagnosis of colorectal cancerGalectin-4 and sulfatides in apical membrane trafficking in enterocyte-like cellsGalectins and their ligands: negative regulators of anti-tumor immunityCyclin-dependent kinase inhibitors and JNK act as molecular switches, regulating the choice between growth arrest and apoptosis induced by galectin-8Determination of modulation of ligand properties of synthetic complex-type biantennary N-glycans by introduction of bisecting GlcNAc in silico, in vitro and in vivo.Carbohydrate recognition by boronolectins, small molecules, and lectins.A novel clinically relevant animal model for studying galectin-3 and its ligands during colon carcinogenesisThe integrated pathway of TGFβ/Snail with TNFα/NFκB may facilitate the tumor-stroma interaction in the EMT process and colorectal cancer prognosis.Expression of galectin-1 in carcinoma-associated fibroblasts promotes gastric cancer cell invasion through upregulation of integrin β1.Thermodynamic Switch in Binding of Adhesion/Growth Regulatory Human Galectin-3 to Tumor-Associated TF Antigen (CD176) and MUC1 Glycopeptides.Low meprin alpha expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries.Circulating Galectin-1 and 90K/Mac-2BP Correlated with the Tumor Stages of Patients with Colorectal CancerRadiation-induced galectin-1 by endothelial cells: a promising molecular target for preferential drug delivery to the tumor vasculatureCrystallization and preliminary X-ray diffraction analysis of mouse galectin-4 N-terminal carbohydrate recognition domain in complex with lactose.Clinicopathological and prognostic significance of galectin-1 and vascular endothelial growth factor expression in gastric cancerExpression patterns suggest that despite considerable functional redundancy, galectin-4 and -6 play distinct roles in normal and damaged mouse digestive tractCell surface markers in colorectal cancer prognosis.The role of galectins in colorectal cancer progression.Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.Biological applications of functionalized calixarenes.Context-dependent multifunctionality of galectin-1: a challenge for defining the lectin as therapeutic target.Galectins as cancer biomarkers.Introduction to glycopathology: the concept, the tools and the perspectivesCyclic neoglycodecapeptides: how to increase their inhibitory activity and selectivity on lectin/toxin binding to a glycoprotein and cells.First demonstration of differential inhibition of lectin binding by synthetic tri- and tetravalent glycoclusters from cross-coupling of rigidified 2-propynyl lactoside.TLR4-mediated galectin-1 production triggers epithelial-mesenchymal transition in colon cancer cells through ADAM10- and ADAM17-associated lactate production.Sweet complementarity: the functional pairing of glycans with lectins.Galectin-1 is silenced by promoter hypermethylation and its re-expression induces apoptosis in human colorectal cancer cellsHypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells.Expression of galectin-3 in the tumor immune response in colon cancer.Promoter SNPs rs116896264 and rs73933062 form a distinct haplotype and are associated with galectin-4 overexpression in colorectal cancer.Galectin-1 expression is associated with tumour immunity and prognosis in gingival squamous cell carcinoma.Structural significance of galectin design: impairment of homodimer stability by linker insertion and partial reversion by ligand presence.Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression.Galectin-8 expression in laryngeal squamous cell carcinoma.Synergistic interaction between galectin-3 and carcinoembryonic antigen promotes colorectal cancer metastasis.Decrease of nuclear reactivity to growth-regulatory galectin-1 in senescent human keratinocytes and detection of non-uniform staining profile alterations upon prolonged culture for galectin-1 and -3.Stromal fibroblasts from basal cell carcinoma affect phenotype of normal keratinocytes.Determination of structural and functional overlap/divergence of five proto-type galectins by analysis of the growth-regulatory interaction with ganglioside GM1 in silico and in vitro on human neuroblastoma cells.High expressions of galectin-1 and VEGF are associated with poor prognosis in gastric cancer patients.
P2860
Q24652981-069E7F3C-458C-4104-BB48-6771DE480443Q24678274-C4D6FABE-E985-4E2C-833F-17A8FBB8AFD1Q27024580-918CB2C6-3CA8-471E-9E0F-FD8AFB611907Q28238607-596C24F1-7767-4CEB-ABCA-2F41EF4F413DQ31033747-DA6878A1-9BF2-4B16-9296-B61FE1DA1CADQ33691290-CB710692-218A-4684-B61B-1CBE9C22845CQ33867523-618F49CF-3E7A-4C1E-9CBD-40CB8AA0395DQ33885041-B9F57026-D6AA-43C9-98DA-5B1EA9C286FAQ35713332-340D562C-AE92-41B5-BAE5-4E70C34FA18CQ35904166-36A8BE52-C2B3-433D-AB3E-4D2C50ACE781Q35954378-0CFC5F57-2FEB-46C9-9394-C134194E55FCQ36095578-7893D6F5-F150-4FCD-AD4E-4F9085A62253Q36652864-123DCEB6-7B5F-4E9F-9981-C04A60EA999FQ36744959-5E615E50-511E-49F1-B085-82F62D388E0DQ36759226-30CABA0C-5BD8-4620-AFBD-666E6DD5AE2FQ36796308-A0C3338F-5F57-4A93-A701-4496199CA4D9Q37845669-0F067DE1-9BA9-44D1-90BA-28EEE9B7732AQ37869015-6D7992E4-4E49-4DCA-830E-57619C4F32EBQ38019412-47FA56F9-A9B3-47C2-AA1E-696F34D1DF3BQ38049083-8CA96A42-C9EE-424B-94D2-C8BC48058E1CQ38071660-7F6E7EA3-BA87-4E7B-B437-6697F9A1E4AAQ38105320-F199A6E1-AC8A-4DF6-8DE6-E6B59C290E17Q38180146-1CDE1195-11A3-4B16-B208-2288BDDC009EQ38337529-82653B22-6255-4858-9191-BD65318880A1Q38347052-B362C947-8FA9-41FD-941B-92FA44BC3736Q38731601-EE2816A4-EB16-4F17-B7CA-2B11E5F9360FQ38766179-ABE91631-6F14-4EEB-BF0F-98B09DE6B7A2Q39625206-EAF5D86C-6288-47C1-9A3F-1628853D24CEQ39696500-1C5C38CA-3EFB-47BB-A0A2-B674BA69A996Q39973740-1FBF42D6-0179-4536-88FB-0962A3DEBEEAQ40197366-FCC4A397-C861-4C8C-B9DC-500BA9D7F203Q40370622-974ACA7A-7CD4-43EC-9B06-FB100509A023Q41183639-0C40F9CB-9249-4301-90C6-5C5162A79C17Q41334598-407BD099-F9CF-4B83-A134-7DC79A7281C5Q41900442-AA1572CA-4BA2-4843-9B93-D7012AFE1AEEQ42241513-F3FB65FB-9C39-459D-820F-FDE76E8DB8BCQ42470447-3E23D42D-9AFA-444E-8025-B15E8FB4D388Q42507597-E05AC32E-ABA4-4301-932F-F1133177B335Q42639630-1DE69CD0-3839-48CA-8B20-C95CB32A5184Q44957730-0B57742B-D76E-4249-81AA-E2A627B69F33
P2860
Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Refined prognostic evaluation ...... mical galectin fingerprinting.
@en
Refined prognostic evaluation ...... mical galectin fingerprinting.
@nl
type
label
Refined prognostic evaluation ...... mical galectin fingerprinting.
@en
Refined prognostic evaluation ...... mical galectin fingerprinting.
@nl
prefLabel
Refined prognostic evaluation ...... mical galectin fingerprinting.
@en
Refined prognostic evaluation ...... mical galectin fingerprinting.
@nl
P2093
P50
P356
P1433
P1476
Refined prognostic evaluation ...... mical galectin fingerprinting.
@en
P2093
Christine Decaestecker
Hugues Legendre
Isabelle Salmon
Jean-Claude Pector
Kojiro Wasano
Nathalie Nagy
Olivier Engels
Robert Kiss
Yehiel Zick
P304
P356
10.1002/CNCR.11268
P407
P577
2003-04-01T00:00:00Z